Showing 1 posts of 1 posts found.
Novartis will make use of a technology developed by Synthetic Genomics Vaccines, a new company set up by genomics pioneer …
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business